Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 867-869, 2016.
Artigo em Chinês | WPRIM | ID: wpr-491107

RESUMO

Objective To compare the clinical effects and safety of two kinds of adjuvant chemotherapy in treatment of patients with colon cancer with Ⅱ-Ⅲ stage after radical resection including 5 -FU/CF scheme and FOLFOX4 scheme.Methods 110 patients with colon cancer with Ⅱ-Ⅲ stage after radical resection were chosen from July 2010 to July 2013 in our hospital and were randomly divided into two groups.A group (55 patients) was given 5-FU/CF scheme and B group (55 patients) received FOLFOX4 scheme.The recurrence and metastasis rate with follow-up,survival time and drug side effects incidence were compared between the two groups.Results The recurrence and metastasis rates with follow-up of B group(18.18%,25.45%) were significantly better than A group (34.55%,63.64%)(χ2 =9.12,8.74,all P0.05).Conclusion Compared with 5-FU/CF scheme,FOLFOX4 scheme in treatment of patients with colon cancer withⅡ-Ⅲstage after radical resection can efficiently reduce the risk of recurrence and metastasis,prolong the survival time and not increase the risk and extent of drug adverse effects.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA